| 000 | 01609 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514031952.0 | ||
| 264 | 0 | _c20021122 | |
| 008 | 200211s 0 0 eng d | ||
| 022 | _a0264-410X | ||
| 024 | 7 |
_a10.1016/s0264-410x(02)00067-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcMichael, Andrew | |
| 245 | 0 | 0 |
_aHIV T cell vaccines, the importance of clades. _h[electronic resource] |
| 260 |
_bVaccine _cMay 2002 |
||
| 300 |
_a1918-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAIDS Vaccines |
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntigen Presentation |
| 650 | 0 | 4 | _aAntigenic Variation |
| 650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
| 650 | 0 | 4 |
_aEpitopes _ximmunology |
| 650 | 0 | 4 |
_aHIV _xclassification |
| 650 | 0 | 4 |
_aHIV Antibodies _xbiosynthesis |
| 650 | 0 | 4 |
_aHIV Antigens _xchemistry |
| 650 | 0 | 4 |
_aHIV Infections _xepidemiology |
| 650 | 0 | 4 |
_aHLA Antigens _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunity, Cellular |
| 650 | 0 | 4 | _aImmunologic Memory |
| 650 | 0 | 4 |
_aInterleukin-2 _ximmunology |
| 650 | 0 | 4 |
_aKenya _xepidemiology |
| 650 | 0 | 4 | _aMacaca |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aNeutralization Tests |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
| 650 | 0 | 4 | _aVaccines, DNA |
| 650 | 0 | 4 | _aVaccines, Synthetic |
| 700 | 1 | _aMwau, Matilu | |
| 700 | 1 | _aHanke, Tomás | |
| 773 | 0 |
_tVaccine _gvol. 20 _gno. 15 _gp. 1918-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0264-410x(02)00067-1 _zAvailable from publisher's website |
| 999 |
_c11883500 _d11883500 |
||